Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism

References

• Ahmad F, Khan RA, Rasheed S. 1994. Preliminary screening of methanolic extracts of Celastrus paniculatus and Tecomella undulata for analgesic and anti-inflammatory activities. J Ethnopharmacol. 42:193–198.
   PubMed Web of Science ®Google Scholar
• Andre VM, Cepeda C, Levine MS. 2010. Dopamine and glutamate in Huntington's disease: a balancing act. CNS Neurosci Ther. 16:163–178.
   PubMed Web of Science ®Google Scholar
• Aziz NA, Van Der Burg JMM, Landwehrmeyer GB, Brundin P, Stijnen T, Roos RAC, Group ES. 2008. Weight loss in Huntington disease increases with higher CAG repeat number. Neurology. 71:1506–1513.
   PubMed Web of Science ®Google Scholar
• Badrul A, Ekramul H. 2011. Anti-Alzheimer and antioxidant activity of Celastrus paniculatus seed. Iran J Pharm Sci. 7:49–56.
   Google Scholar
• Bhanumathy M, Chandrasekar SB, Chandur U, Somasundaram T. 2010a. Phyto-pharmacology of Celastrus paniculatus: an overview. Int J Pharm Sci Rev Res. 2:176–181.
   Google Scholar
• Bhanumathy M, Harish MS, Shivaprasad HN, Sushma G. 2010b. Nootropic activity of Celastrus paniculatus seed. Pharm Biol. 48:324–327.
   PubMed Web of Science ®Google Scholar
• Bidwai PP, Wangoo D, Bhullar NK. 1990. Antispermatogenic action of Celastrus paniculatus seed extract in the rat with reversible changes in the liver. J Ethnopharmacol. 28:293–303.
   PubMed Web of Science ®Google Scholar
• Chakraborty J, Singh R, Dutta D, Naskar A, Rajamma U, Mohanakumar KP. 2014. Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington's disease. CNS Neurosci Ther. 20:10–19.
   PubMed Web of Science ®Google Scholar
• Djousse L, Knowlton B, Cupples LA, Marder K, Shoulson I, Myers RH. 2002. Weight loss in early stage of Huntington's disease. Neurology. 59:1325–1330.
   PubMed Web of Science ®Google Scholar
• Dong X, Wang Y, Qin Z. 2009. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin. 30:379–387.
   PubMed Web of Science ®Google Scholar
• Ellman GL. 1959. Tissue sulfhydryl groups. Arch Biochem Biophys. 82:70–77.
   PubMed Web of Science ®Google Scholar
• Frank S. 2014. Treatment of Huntington's disease. Neurotherapeutics. 11:153–160.
   PubMed Web of Science ®Google Scholar
• Gattu M, Boss LK, Terry VA, Buccafusco JJ. 1997. Reversal of scopolamine-induced deficits in navigational performance by the seed oil of Celastrus paniculatus. Pharmacol Biochem Behav. 57:793–799.
   PubMed Web of Science ®Google Scholar
• Gil-Mohapel J, Brocardo PS, Christie BR. 2014. The role of oxidative stress in Huntington's disease: are antioxidants good therapeutic candidates? Curr Drug Targets. 15:454–468.
   PubMed Web of Science ®Google Scholar
• Godkar PB, Gordon RK, Ravindran A, Doctor BP. 2003. Celastrus paniculatus seed water soluble extracts protect cultured rat forebrain neuronal cells from hydrogen peroxide-induced oxidative injury. Fitoterapia. 74:658–669.
   PubMed Web of Science ®Google Scholar
• Godkar PB, Gordon RK, Ravindran A, Doctor BP. 2004. Celastrus paniculatus seed water soluble extracts protect against glutamate toxicity in neuronal cultures from rat forebrain. J Ethnopharmacol. 93:213–219.
   PubMed Web of Science ®Google Scholar
• Godkar PB, Gordon RK, Ravindran A, Doctor BP. 2006. Celastrus paniculatus seed oil and organic extracts attenuate hydrogen peroxide- and glutamate-induced injury in embryonic rat forebrain neuronal cells. Phytomedicine. 13:29–36.
   PubMed Web of Science ®Google Scholar
• Gopinath K, Sudhandiran G. 2012. Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway. Neuroscience. 227:134–143.
   PubMed Web of Science ®Google Scholar
• Gornall AG, Bardawill CJ, David MM. 1949. Determination of serum proteins by means of the biuret reaction. J Biol Chem. 177:751–766.
   PubMed Web of Science ®Google Scholar
• Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 126:131–138.
   PubMed Web of Science ®Google Scholar
• Hertog HJ, Hackman TJ, Nanavati DD, Dev S. 1973. Malkanguniol, one of the polyalcohols from Celastrus paniculatus Willd. Tetrahedron Lett. 11:845–848.
   Google Scholar
• Johri A, Beal MF. 2012. Antioxidants in Huntington's disease. Biochim Biophys Acta. 1822:664–674.
   PubMed Web of Science ®Google Scholar
• Kono Y. 1978. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys. 186:189–195.
   PubMed Web of Science ®Google Scholar
• Krobitsch S, Kazantsev AG. 2011. Huntington's disease: from molecular basis to therapeutic advances. Int J Biochem Cell Biol. 43:20–24.
   PubMed Web of Science ®Google Scholar
• Kumar MHV, Gupta YK. 2002. Antioxidant property of Celastrus paniculatus Willd.: a possible mechanism of enhancing cognition. Phytomedicine. 9:302–311.
   PubMed Web of Science ®Google Scholar
• Kumar P, Kumar A. 2009a. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. J Med Food. 12:591–600.
   PubMed Web of Science ®Google Scholar
• Kumar P, Kumar A. 2009b. Protective effects of epigallocatechin gallate following 3-nitropropionic acid-induced brain damage: possible nitric oxide mechanisms. Psychopharmacology. 207:257–270.
   PubMed Web of Science ®Google Scholar
• Kumar P, Kumar A. 2010. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide. Behav Brain Res. 206:38–46.
   PubMed Web of Science ®Google Scholar
• Kumar P, Padi SSV, Naidu PS, Kumar A. 2006. Protective effect of antioxidants on 3-nitropropionic acid induced oxidative stress and cognitive impairment. Ann Neurosci. 13:41–47.
   Google Scholar
• Lekha G, Kumar BP, Rao SN, Arockiasamy I, Mohan K. 2010. Cognitive enhancement and Neuroprotective effect of Celastrus paniculatus Willd. seed oil (Jyothismati oil) on male Wistar rats. J Pharm Sci Technol. 2:130–138.
   Google Scholar
• Luck H. 1971. Catalase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. New York: Academic Press; p. 885–893.
   Google Scholar
• Malik J, Choudhary S, Kumar P. 2015. Protective effect of Convolvulus pluricaulis standardized extract and its fractions against 3-nitropropionic acid-induced neurotoxicity in rats. Pharm Biol. 53:1448–1457.
   PubMed Web of Science ®Google Scholar
• Mittal SK, Eddy C. 2013. The role of dopamine and glutamate modulation in Huntington disease. Behav Neurol. 26:255–263.
   PubMed Web of Science ®Google Scholar
• Nadkarni KM. 2002. Indian Materia Medica. New Delhi: Popular Prakashan Pvt. Ltd.
   Google Scholar
• Nalini K, Karnath KS, Rao A, Aroor AR. 1995. Effects of Celastrus paniculatus on passive avoidance performance and biogenic amine turnover in albino rats. J Ethnopharmacol. 47:101–108.
   PubMed Web of Science ®Google Scholar
• Palmer GC. 2001. Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies. Curr Drug Targets. 2:241–271.
   PubMed Web of Science ®Google Scholar
• Perez-De La Cruz V, Elinos-Calderon D, Robledo-Arratia Y, Medina-Campos ON, Pedraza-Chaverri J, Ali SF, Santamaria A. 2009. Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease. Behav Brain Res. 199:210–217.
   PubMed Web of Science ®Google Scholar
• Picconi B, Passino E, Sgobio C, Bonsi P, Barone I, Ghiglieri V, Pisani A, Bernardi G, Ammassari-Teule M, Calabresi P. 2006. Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons. Neurobiol Dis. 22:143–152.
   PubMed Web of Science ®Google Scholar
• Rajkumar R, Kumar EP, Sudha S, Suresh B. 2007. Evaluation of anxiolytic potential of Celastrus oil in rat models of behaviour. Fitoterapia. 78:120–124.
   PubMed Web of Science ®Google Scholar
• Saydoff JA, Liu LS, Garcia RA, Hu Z, Li D, von Borstel RW. 2003. Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease. Brain Res. 994:44–54.
   PubMed Web of Science ®Google Scholar
• Shinomol GK, Muralidhara. 2011. Bacopa monnieri modulates endogenous cytoplasmic and mitochondrial oxidative markers in prepubertal mice brain. Phytomedicine. 18:317–326.
   PubMed Web of Science ®Google Scholar
• Silva RH, Abilio VC, Kameda SR, Takatsu-Coleman AL, Carvalho RC, Ribeiro Rde A, Tufik S, Frussa-Filho R. 2007. Effects of 3-nitropropionic acid administration on memory and hippocampal lipid peroxidation in sleep-deprived mice. Prog Neuropsychopharmacol Biol Psychiatry. 31:65–70.
   PubMed Web of Science ®Google Scholar
• Sugino T, Nozaki K, Takagi Y, Hattori I, Hashimoto N, Yodoi J. 1999. Expression and distribution of redox regulatory protein, thioredoxin after metabolic impairment by 3-nitropropionic acid in rat brain. Neurosci Lett. 275:145–148.
   PubMed Web of Science ®Google Scholar
• Tandon N, Sharma P. 2011. Quality standards of Indian medicinal plants. New Delhi: Medicinal Plants Unit, Indian Council of Medical Research.
   Google Scholar
• Tu YQ, Chen YZ. 1993. Sesquiterpenoids from Celastrus paniculatus. J Nat Prod. 56:122–125.
   Web of Science ®Google Scholar
• Tu YQ, Wu TX, Li ZZ, Zhen T, Chen YZ. 1991. Sesquiterpene polyol esters from Celastrus paniculatus. J Nat Prod. 54:1383–1386.
   Web of Science ®Google Scholar
• Tunez I, Santamaria A. 2009. Model of Huntington's disease induced with 3-nitropropionic acid. Rev Neurol. 48:430–434.
   PubMed Web of Science ®Google Scholar
• Tunez I, Tasset I, Cruz VPL, Santamaria A. 2010. 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future. Molecules. 15:878–916.
   PubMed Web of Science ®Google Scholar
• Wagner H, Heckkel E, Sonnenbichler J. 1974. Isolation and structures of a new sesquiterpene (malkangunin) and two new sesquiterpene alkaloids (celapanin, celapanigin) from Celastrus paniculatus Willd. Tetrahedron Lett. 2:213–216.
   Google Scholar
• Wills ED. 1966. Mechanisms of lipid peroxide formation in animal tissues. Biochem J. 99:667–676.
   PubMed Web of Science ®Google Scholar